Housekeeping while brain's storming Validation of normalizing factors for gene expression studies in a murine model of traumatic brain injury by Rhinn, Hervé et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Molecular Biology
Open Access Research article
Housekeeping while brain's storming Validation of normalizing 
factors for gene expression studies in a murine model of traumatic 
brain injury
Hervé Rhinn*1, Catherine Marchand-Leroux2, Nicole Croci2, 
Michel Plotkine2, Daniel Scherman1 and Virginie Escriou1
Address: 1Inserm, U640, Paris, F-75006 France; CNRS, UMR8151, Paris, F75006 France; Université Paris Descartes, Faculté des Sciences 
Pharmaceutiques et Biologiques, Chemical and Genetic Pharmacology Laboratory, Paris, F-75006 France; Ecole Nationale Supérieure de Chimie 
de Paris, Paris, F-75005 France and 2Unité de pharmacologie de la circulation cérébrale, Université Paris Descartes, Faculté des Sciences 
Pharmaceutiques et Biologiques, Paris, F-75006 France
Email: Hervé Rhinn* - herve.rhinn@gmail.com; Catherine Marchand-Leroux - catherine.marchand@univ-paris5.fr; 
Nicole Croci - nicole.croci@univ-paris5.fr; Michel Plotkine - michel.plotkine@univ-paris5.fr; Daniel Scherman - daniel.scherman@univ-
paris5.fr; Virginie Escriou - virginie.escriou@univ-paris5.fr
* Corresponding author    
Abstract
Background: Traumatic brain injury models are widely studied, especially through gene expression, either to
further understand implied biological mechanisms or to assess the efficiency of potential therapies. A large
number of biological pathways are affected in brain trauma models, whose elucidation might greatly benefit from
transcriptomic studies. However the suitability of reference genes needed for quantitative RT-PCR experiments
is missing for these models.
Results: We have compared five potential reference genes as well as total cDNA level monitored using Oligreen
reagent in order to determine the best normalizing factors for quantitative RT-PCR expression studies in the early
phase (0–48 h post-trauma (PT)) of a murine model of diffuse brain injury. The levels of 18S rRNA, and of
transcripts of β-actin, glyceraldehyde-3P-dehydrogenase (GAPDH), β-microtubulin and S100β were determined
in the injured brain region of traumatized mice sacrificed at 30 min, 3 h, 6 h, 12 h, 24 h and 48 h post-trauma.
The stability of the reference genes candidates and of total cDNA was evaluated by three different methods,
leading to the following rankings as normalization factors, from the most suitable to the less: by using geNorm VBA
applet, we obtained the following sequence: cDNA(Oligreen); GAPDH > 18S rRNA > S100β > β-microtubulin >
β-actin; by using NormFinder Excel Spreadsheet, we obtained the following sequence: GAPDH >
cDNA(Oligreen) > S100β > 18S rRNA > β-actin > β-microtubulin; by using a Confidence-Interval calculation, we
obtained the following sequence: cDNA(Oligreen) > 18S rRNA; GAPDH > S100β > β-microtubulin > β-actin.
Conclusion: This work suggests that Oligreen cDNA measurements, 18S rRNA and GAPDH or a combination
of them may be used to efficiently normalize qRT-PCR gene expression in mouse brain trauma injury, and that β-
actin and β-microtubulin should be avoided.
The potential of total cDNA as measured by Oligreen as a first-intention normalizing factor with a broad field of 
applications is highlighted. Pros and cons of the three methods of normalization factors selection are discussed. 
A generic time- and cost-effective procedure for normalization factor validation is proposed.
Published: 8 July 2008
BMC Molecular Biology 2008, 9:62 doi:10.1186/1471-2199-9-62
Received: 10 December 2007
Accepted: 8 July 2008
This article is available from: http://www.biomedcentral.com/1471-2199/9/62
© 2008 Rhinn et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Molecular Biology 2008, 9:62 http://www.biomedcentral.com/1471-2199/9/62
Page 2 of 12
(page number not for citation purposes)
Background
Real-time RT-PCR, which allows to measure any chosen
RNA with great accuracy over a large dynamic range, has
become the gold-standard for nucleic acid quantification.
It has also opened new investigations fields, since very
small amount of RNA is needed, allowing transcripts from
low-expressed genes or from very small samples to be
quantified.
If constant developments in both reagents and data anal-
ysis make real-time PCR measurements more and more
accurate and reliable, many considerations have to be
taken to convert this technical precision into biologically
relevant data. Factually, real-time RT-PCR gives access to
the number of copies of a chosen sequence in a cDNA
solution, which is obtained from RNA extracted from a
known quantity of tissue. The biologically relevant infor-
mation that has to be ultimately obtained is the global
expression level of the chosen gene in the tested sample,
at least relatively to another sample.
The quantification of a target gene in a given sample needs
three majors steps: RNA/mRNA extraction, reverse tran-
scription of the extracted RNA, and qPCR (quantitative
PCR) processing of the synthesised cDNA. A control nor-
malization may be performed at each step to level out dis-
similarities between samples [1].
The first possible normalization is by equalizing samples
size, such as cell number or tissue weight. This is the easi-
est and the most intuitive measure. However, its position
upstream of the reactions sequence does not allow to cor-
rect for the distortions generated by downstream manipu-
lations, especially by RNA extraction, whose efficiency
may broadly vary from one sample to another.
The second method consists in normalizing samples
according to RNA content after its extraction. This how-
ever does not take into account the reverse transcription
efficiency, known to vary from one sample to the other
[2].
Thus, a downstream normalization method appears to be
the most effective. This may be performed by measuring
the expression level of a gene transcript expressed in the
sample, as an endogenous control for the different reac-
tion steps. The housekeeping term, which is often applied
to these genes, was initially given to genes that are neces-
sary for the function of each cell. As a matter of fact, they
have to be expressed in each cell type. The most typical
case is β-actin, a cornerstone of the inner architecture of
the cell. This makes housekeeping genes suitable for
organism-wide positive controls for many cDNA-based
techniques, but does not ensure their expression levels to
be equals. The expression levels of usual housekeeping
genes has however been shown to vary in some condi-
tions [1].
If the belief in the existence of perfect reference genes,
whose levels would remain unchanged in each cell what-
ever the tissue or the experimental conditions, is known to
be more idealistic than real, reference genes have to be
chosen specifically for a given experiment, on the basis of
the stability of their expression in the subset of studied tis-
sues and experimental conditions one is interested in. In
consequence, the use of internal controls implies a proper
validation for each experimental condition, as the use of
unappropriate normalizing factors, with unconstant
expression levels, would generate discrepancies in nor-
malized expression results [3]. Several methods have been
described for that purpose [4-7].
In addition to the use of reference genes, alternative nor-
malization procedures have been proposed for RT-PCR:
the addition of known quantity of artificial RNA mole-
cules to extracted RNA prior to RT reaction [8], or the use
of an oligo-dT linked artificial target sequence quantifia-
ble by quantitative PCR (qPCR) [9] or the total cDNA
quantification by fluorescent dyes [10].
In the specific context of brain trauma, sample size meas-
urement is especially doubtful, since the oedema resulting
from the trauma [11] may enhance brain water content,
hence lowering the cellular density of a given weight of tis-
sue. This effect may also be strengthened, as necrosis and
apoptosis are known to be major post-trauma events
[12,13].
We have reviewed the use of PCR to quantify mRNA levels
in mouse and rat traumatic mechanical brain injury mod-
els for the five last years. We have identified 22 qPCR and
17 semi quantitative PCR studies. About 85% of them
used a reference gene for normalization, while the others
only used RNA quantification for this purpose.
GAPDH has been up to now the most commonly used ref-
erence gene in qPCR [14-24] and the second one [25-28]
for sqPCR (semi-quantitative PCR). The use of β-actin has
been predominant for sqPCR [29-36], but less frequent
for qPCR, to the benefit of 18S rRNA [37-41]. We have
found no correlation between the choice of a reference
gene and the pathological model (Controlled Cortical
Injury (CCI), Closed Head Injury (CHI) or Fluid Percus-
sion Injury (FPI)) or species. Strikingly, a single reference
gene has been used in all the experiments, without refer-
ence to a prior validation, whereas the use of more than
one reference gene is widely encouraged [4], and the need
for validation highlighted [1,3]. Indeed, the choice of ref-
erence genes is especially crucial for brain trauma studies,
where many biological pathways are implicated (inflam-BMC Molecular Biology 2008, 9:62 http://www.biomedcentral.com/1471-2199/9/62
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mation, hypoxia, apoptosis, neovascularisation...), result-
ing in numerous gene expression changes, which are thus
likely to include or affect potential reference genes.
The present study aims at the validation of optimal nom-
alizing factors(NF) for RT-qPCR-based transcriptional
studies of an early phase of a murine model of traumatic
diffuse brain injury.
RT-qPCR was used to determine the expression levels of
five potential reference genes. Total cDNA level was also
measured using Oligreen reagent and considered as an
other potential NF. These six candidates were compared
using different NF-selection methods.
Results
Reference genes and total cDNA level
After induction of trauma, 10 mice were sacrificed at 30
min, 3 h, 6 h, 12 h, 24 h and 48 h, and RNA was extracted
from the lesionnal zone of injured brains or from the
equivalent zone of uninjuried control mice brains, then
reverse transcribed. The expression level of 18S rRNA, β-
microtubulin, S100β, β-actin and GAPDH were measured
by real-time PCR for each individual cDNA.
Oligreen reagent is a dye that emits fluorescence at 500/
520 nm when bound to single-stranded DNA, but is
insensitive to free nucleotides and to very short oligonu-
cleotides. However, Oligreen emits fluorescence in the
presence of RNA at room temperature; its use for cDNA
quantification therefore implies to work at 80°C to specif-
ically quantify reverse-transcribed cDNA [43]. Levels of
reference genes at different time post-trauma, as measured
by qPCR and of total cDNA as measured using Oligreen
reagent, are represented on Fig. 1.
ANOVA
A statistical test was applied to look for significant differ-
ences between two experimental conditions for each NF
level. As the variance equality hypothesis was verified for
each of them (no significant variance differences detected
with a Hartley test for a confidence level of 95%), a one-
factor ANOVA test was used, with a Fischer's test to detect
significant differences (p < 0.05) between two groups, for
a given NF expression level.
The expression level fluctuations between time groups
were found to be significant for β-actin, S100β and β-
microtubulin. No significant differences were detected
from one group to another for GAPDH, 18S rRNA and
cDNA (Oligreen).
Significant differences between experimental groups
clearly make the tested NF unsuitable to normalize sam-
ple of the tested experimental set. The expression level of
β-actin, S100β  and  β-microtubulin should thus be
avoided as a NF for the present experimental model.
To further study the suitability of the studied normaliza-
tion factors, three published selection methods were
applied: geNorm analysis [4], Normfinder analysis [6]
and a confidence interval based method [7].
GeNorm analysis
Gene stability analysis was performed using the geNorm
VBA applet as described in [4]. Briefly, the basic assump-
tion of this method is that the ratio of two perfect refer-
ence genes should be constant throughout the different
experimental conditions. The inter-condition variability
of this ratio is thus evaluated for each experimental condi-
tion and for each couple of reference gene, and a gene-sta-
bility-measure M is calculated for each candidate. This
reflects the average pair-wise variability between one puta-
tive reference gene and all the others. The less stable can-
didate (i.e. with the highest M value) is then excluded as
the least suitable NF, and a new step of M-values calcula-
tion has then to be performed because the former inclu-
sion of the less stable gene had influenced other M values.
By sequential exclusions, the two most-stably expressed
genes are selected. The ranking of the studied NF accord-
ing to their M value, as calculated by the GeNorm software
was, from the most stable to the least:
GAPDH – cDNA(Oligreen)>18S rRNA > S100β > β-actin
> β-microtubulin (Fig. 2A).
As proposed by Vandersompele et al. [4], the use of a geo-
metric mean of multiple NF among the best ranked
should ensure a more accurate normalization. The choice
of NF to be included starts from the most stable NF, by a
step wise inclusion of the next-ranking NF and the influ-
ence of the inclusion on the overall stability is plotted by
the GeNorm software (Fig. 2B). A strong instability eleva-
tion implies that the inclusion is detrimental, and that the
last included NF should thus be discarded. In our case,
GeNorm method leads to the use of the geometric mean
of total cDNA and GAPDH levels for the best normaliza-
tion.
- Normfinder analysis
A model-based approach, was used as an another tech-
nique to rank the best potential reference genes, using the
Excel Spreadsheet Normfinder [6]. The criteria for sample
sizes (n>8) and candidate RG (n>3) were met. Briefly, for
one given sample and one given candidate reference gene,
the log-transformed measured level is formulated as the
sum of three terms: the general expression level of the
gene in the experimental group to which the sample
belongs, the amount of mRNA in the sample, and the ran-
dom variation caused by biological and experimental fac-BMC Molecular Biology 2008, 9:62 http://www.biomedcentral.com/1471-2199/9/62
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Level of normalizing factors at various time post-trauma Figure 1
Level of normalizing factors at various time post-trauma. The levels of 18S rRNA, β-microtubulin, S100β, β-actin and 
GAPDH as measured by real-time PCR, and cDNA level as measured with Oligreen were determined at the indicated time 
point post-trauma. Each point corresponds to the measured level for one individual sample, normalized to the mean of all indi-
vidual values at all times Horizontal bars represent the median of the measures for the group, vertical crosses represent the 
arithmetic mean. (C): control.
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Genorm output Figure 2
Genorm output. A: Expression stability values (M) of the candidate normalization factors, during the stepwise exclusion of 
least stable normalization factors. Candidate normalization factors are ranked from the least stable to the most stable (left to 
right). B: Determination of the optimal number of normalization factors to be used, based on the analysis of pairwise variation 
(V) between normalization factors. A low value of V means that the inclusion of an additional normalization factor would not 
lead to a increase in stability.
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tors. The latter term is used to calculate an intra-group
variation, while the first term permits to evaluate an inter-
group variability for the considered NF. Both variations
estimations are combined in a stability value used to rank
the NF.
The ranking of each NF according to its stability value as
calculated by the Normfinder software was, from the most
stable to the least:
GAPDH>cDNA(Oligreen)> S100β >18S rRNA > β-actin >
β-microtubulin (Fig. 3).
- Confidence-Interval method
A third approach has been used, based on the one pre-
sented in Haller et al. [7]. Equivalence testing is similar to
classical statistical tests, but while most of them are based
on the rejection of a relative closeness hypothesis to prove
a significant difference between two means, equivalence
testing relies on the rejection of an hypothese of a relative
difference between two means to prove their significant
closeness.
This can be tested by classical t-test, but, for a given level
of confidence alpha, one can proceed more visually
through a confidence interval calculation, which is the
most-used method for statistical assessment of clinical tri-
als.
Briefly, two samples Ti and Tj, with expression levels μi and
μj, are considered to be equivalent for a confidence level
alpha if their confidence interval Iij, centered on μi - μj and
Normfinder stability values output Figure 3
Normfinder stability values output.
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whose length is based on a Student t-distribution depend-
ing of the distributions of the two samples (detailed in
Haller et al.) is such as Iij ⊂ [-ε, ε], epsilon being an arbi-
trarly chosen treshold. Moreover, if 0 ∉ Iij, the two groups
are significantly different for the confidence level.
When dealing with expression levels, intrinsic meaning
has to be found in ratio rather than in absolute difference.
We thus worked with log-transformed expression levels
for equivalence testing. In this way, the limit epsilon that
has to be chosen is equivalent to a fold-change. We chose
to set it to 1, which means an expression ratio between the
two compared groups inferior to two.
The confidence intervals for log-transformed normalized
NF levels were calculated for each couple of experimental
groups and for all NF, with 95% confidence levels (Fig. 4).
Two groups were said to be equivalent with 95% confi-
dence if their confidence level is included in [-1;1].
Measured levels were found to be equivalent between all
groups for cDNA(Oligreen).
For 18S rRNA and GAPDH, the expression levels were
found not to be equivalent for two couples of groups out
of twenty-one. It was the case for 8 combinations for
S100β, 18 for β-microtubulin and 19 for β-actin (Fig. 5)
An equivalence-based ranking thus appears to be:
cDNA(Oligreen)> 18S rRNA-GAPDH> S100β > β-micro-
tubulin > β-actin
Discussion
We have used the Oligreen reagent to quantify the cDNA
effectively synthesised during the RT step. Whatever the
procedure for NF choice, cDNA as measured by Oligreen
ranked among the two best. As its use appears to be vali-
dated for the present model, it should also be very attrac-
tive for other cases, since small variability is unlikely to
depend on experimental conditions, in contrast to other
reference genes.
To ensure that the overall high stability of Oligreen-
assayed cDNA is not an artefact, we compared for each
sample the mean of all studied reference genes levels to
the measured Oligreen level. The aim is to ensure that Oli-
green reflects the level of cDNA in each sample. The appli-
cation of the previously used selection procedures for
RNA input – equal by definition to 1 μg for each sample –
would indeed have led to the systemic selection of RNA
quantification as the best normalizing factor, with both
intra- and inter- group variation equal to zero. RNA level
is however obviously not an appropriate normalizer, as it
does not encompasses RT efficiency. As the mean of all the
gene expression levels measured is likely to be proportion-
nal to the cDNA content, studying the correlation between
this average expression level and the Oligreen level for
each sample appears as a good mean to evaluate whether
Oligreen measurement is proportionnal to the cDNA con-
tent or not. A significant correlation was found using a
Pearson test (p-value < 0.0001, Pearson coefficient: 0.64)
and the correlation plot (Fig. 6) shows that Oligreen
measurements effectively reflect cDNA levels in the sam-
ples, as it correlates well with the the mean of different
genes expression levels.
Oligreen thus appears to be a good candidate for a generic
NF in quantitative RT-PCR experiments. Its use may be
furthermore refined with alternative RT protocols, such as
an oligo dT-primed cDNA synthesis. In such a case, Oli-
green would reflect the level of effectively reverse-tran-
scribed mRNA, in contrast to total RNA in the present
study.
The use of Oligreen combined to a standard curve of
known DNA concentration could moreover allows a pre-
cise cDNA quantification. In parallel to an absolute quan-
tification of target genes, one could thus formulate the
expression level of a studied gene, as the number of copies
per microgram of cDNA, which would have a stronger
intrinsic meaning and could open the gate for easier intra-
experiments meta-analysis.
The question remains open whether the fact of combining
Oligreen measurements to the expression level of internal
control (18S rRNA and GAPDH in our case) brings more
accuracy.
Following a confidence-interval based methodology, Oli-
green appeared as the only NF for which all groups were
found to be equivalent to each other, but one has to keep
in mind the arbitrary choice of fold-change cut-off level
and confidence levels: 18S rRNA and GAPDH appear to
be very close to equivalence and thus appear as acceptable
normalizing factors.
When working with confidence levels, an arbitrary level of
fold change has to be set. A possible criterion for assessing
the pertinence of a chosen cut-off fold-change may come
from the observation of confidence intervals Iii calculated
for a group with itself: as a group is trivially equivalent to
itself, the calculated confidence interval is nothing but the
reflection of the group's standard deviation. It would thus
make little sense to choose a cut-off fold change that
would not lead to the conclusion that a group is equiva-
lent to itself. This consideration excluded the initially-
considered choice of 1.5 as a cut-off fold-change in our
case, and led to the use of 2 as a cut-off fold-change for the
study. A standardized confidence interval approach,
which remains to be developped, should thus set the cut-BMC Molecular Biology 2008, 9:62 http://www.biomedcentral.com/1471-2199/9/62
Page 8 of 12
(page number not for citation purposes)
off fold change in function of the intra-groups confidence
intervals. One has however to keep in mind that alpha
level is arbitrary too, and that its value has a direct effect
(through t-distribution) on the interval size: lowering cut-
off fold change is in some extent equivalent to setting a
higher confidence level alpha. These two values have thus
to be chosen in a concerted manner to make sense.
Among the different procedures of normalizing factors
that were applied, two criteria appear to be determinant.
On one hand, one criterion is whether the method takes
into account the belonging of a sample to an experimental
group (either a tissue, a differentially treated sample, or a
given point of a time series). This should ultimately be a
requirement, as the final goal of many, if not all, gene
expression experiments consists in levels comparison
between different groups. This is handled by model-based
and confidence intervals based methodology, but not by
pair-wise approach. However, if the Normfinder software
evaluates inter-group variability, its effect is combined to
intra-groups variability to calculate a candidate's stability.
This implies that a NF with a low variability in each group,
but with an expression level clearly different in one single
group, will be considered as the optimal NF, when com-
pared to candidate with greater variability in each group
but with almost no differences between groups (data not
shown). This is also the case for the GeNorm software,
and is probably the worst type of error that may occur
while selecting a NF, as it will generate systematic errors in
normalized gene expression results.
On the other hand, a second determinant criterion for
eliciting a NF is the absolute or relative character of its
evaluation as a potential NF. This means whether its sole
expression values, as measured for every sample, are suffi-
cient or if it has to be compared to other potential normal-
izing factor. The relative comparison is clearly the basis of
the pair-wise method, but is also implicitly present in the
model-base approach for the calculation of both intra-
and inter- group variations (through the use of  , vari-
ance of αig in the calculation of the stability value ρi (Eq. C
and D, [6])). The main drawback of these circular meth-
odologies is the risk of selecting co-regulated genes. One
would thus need to examinate many carefully chosen
potential NF (i.e. from biological pathways as distinct as
possible) in order to ensure that a majority of them is not
co-regulated, the quality of the NF selection being
strongly dependant of the number of studied candidates.
The equivalence interval approach enables to evaluate
each NF candidate separately. This permits to imagine a
sequential approach to assess reference gene: rather than
gathering an as large as possible pool of potential NF can-
didates, then measuring their expression level and sorting
them to determine the most appropriate among them,
one may choose a first-intention potential NF and test it
ab nihilo. If the test concords with previously fixed criteria,
then the candidate is validated as a NF, otherwise, an
additional candidate has to be tested. As it seems best to
normalize with more than one reference gene, one may
stop the selection procedure when two or three candidates
are positively evaluated.
An additional interesting feature of an absolute evalua-
tion is that it enables researchers to proceed to a post-hoc
validation of their previously chosen NF on the sole basis
of already-existing data analysis, with no need to run addi-
tional experiments with additional NF. This appears to be
especially interesting when the biological material was
totally used for previous reactions.
Despite its less restricted use, probably due to the lack of
an easy-to-handle Excel spreadsheet as it is the case with
ˆ g
95% Confidence intervals for equivalence between experi- mental groups Figure 4
95% Confidence intervals for equivalence between 
experimental groups. TG/TG' corresponds to the interval 
calculated between group G and group G'. With T0: control 
group and T1, T2, T3, T4, T5 and T6 trauma groups sacri-
ficed at 30 min, 3 h, 6 h, 12 h, 24 h and 48 h respectively. For 
symmetrical reasons, since Iij = Iji, only (Ii,j)i≤j are plotted. For 
each of the normalization factor: If 0 ∉ Iij, its level is signifi-
cantly different between experimental conditions i and j. If Iij 
⊂ [-ε; ε], its level is equivalent between experimental condi-
tions i and j. A: Oligreen measurements; B: 18S rRNA; C: 
S100β; D:GAPDH; E: β-actin; F: β-microtubulin.
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GeNorm and Normfinder, the confidence interval based
method appears to be the most powerful and most ade-
quate for NF selection. A scoring procedure based on this
approach, allowing a ranking of different NF, along with
an automated easy-to-handle automated application, may
be an interesting tool to develop.
Conclusion
In conclusion, we present here the first study aiming at the
identification of optimal normalizing factors in a model
of traumatic brain injury. If the use of β-actin and β-
microtubulin appears to be avoided, the combination of
different methods leads us to suggest the use of a geomet-
ric mean of 18S rRNA, GAPDH and total cDNA as meas-
ured with Oligreen. The use of cDNA measurement with
Oligreen has been validated in the present case and is
encouraged as first-intention generic normalization fac-
tor. The present study also highlights the interest of using
confidence interval for normalizing factor accuracy assess-
ing, and opens the way for an iterative, time and cost-
effective normalizing factor selection procedure.
Methods
Closed head injury model
Male CD-1 mice (IFFA Credo, France), weighting 21–24 g,
were housed at room temperature under controlled light
conditions (12 h light: 12 h dark) with food and water ad
libitum. The murine model of diffuse head injury was
used as previously described [11]. Mice were briefly anes-
thetized under 2% halothane balanced with air and oxy-
gen. Closed head trauma was induced by a 50 g weight
dropped from 32-cm height along a stainless steel string.
This model typically results in a mortality of 30% within
the first 10 min following the impact, with no observed
delayed mortality. Animal care was in compliance with
French regulations on protection of animals used for
experimental research and with the EC regulations (Offi-
cial Journal of European Community L35812/18/1986).
cDNA preparation
Mice were sacrificed at different times (30 min, 3 h, 6 h,
12 h, 24 h and 48 h post-trauma). Brains were immedi-
ately removed. Column-shaped samples of approximately
10 mg were taken vertically around the lesion site using a
4 mm punch and put in RNAlater solution (QIAGEN),
and were kept at 4°C for further extraction of total RNA
using the Rneasy kit (QIAGEN). RNA concentration was
assessed using a NanoDrop ND-1000 Spectrophotometer
(Nanodrop). One microgram of total RNA was reverse
transcribed in a final volume of 20 μl containing 4 μL of
5× RT buffer, 20 units of RNasin RNase inhibitor
(Promega), 10 mM DDT, 100 units of Superscript II
RNase H-reverse transcriptase (Invitrogen), 3 mM random
hexamers (Invitrogen). The samples were incubated at
20°C for 10 min, 42°C for 30 min and 99°C for 5 min.
Real-time PCR
PCR primers for tested reference gene were chosen in pub-
lished articles, for their common use as reference genes
and their belonging to different biological pathways (Fig.
7). Real-time PCR reactions were carried out using ABI
PRISM 7900HT Sequence Detection System (Applied Bio-
systems) in a 384-well, clear optical reaction plate with
optical adhesive covers (Applied Biosystems). Reactions
were run in a 5 μl volume in duplicate, with 2 μL of cDNA
solution and 3 μL of a homemade target-specific mix com-
posed of 5/6 2× Power SYBR Green Master Mix (Applied
Biosystems) and 1/6 of 100 mM primers solution. The
PCR program was: 95°C for 10 min, followed by 45 cycles
of (15 seconds at 95°C; 1 min at 60°C). Product specifi-
city was assessed by 3% agarose gel electrophoresis fol-
lowed by ethidium bromide staining.
For each PCR well, raw fluorescence data were exported
and a curve-fitting method was applied to evaluate indi-
vidual efficiencies [42]. As for each target, calculated effi-
ciencies appeared to be homogeneous throughout
Schematic results for confidence interval calculations Figure 5
Schematic results for confidence interval calcula-
tions. Confidence interval are calcultated using a cut-off fold 
change = 2 and 95% confidence level. White squares: the two 
groups are equivalent for the considered NF. Grey squares: 
the two groups are not equivalent for the considered NF. 
Dashed squares: the two groups are significantly different for 
the considered NF. With T0: control group and T1, T2, T3, 
T4, T5 and T6 trauma groups sacrificed at 30 min, 3 h, 6 h, 
12 h, 24 h and 48 h respectively.BMC Molecular Biology 2008, 9:62 http://www.biomedcentral.com/1471-2199/9/62
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samples, the efficiency for each target was considered as
shared for all wells. This efficiency was set as the mean of
the fitted individual efficiencies. Individual Ct values
exported from the SDS software (Applied Biosystems)
were used to calculate the relative expression level of tar-
get t in sample s: 
As dealing with numerous normalizing factors, these rela-
tive expression levels were normalized for each target, for
easier calculation and comparison.
Oligreen measurements
Fluorescence measurements was carried out using ABI
PRISM 7900HT Sequence Detection System (Applied Bio-
systems) in a 384-well, clear optical reaction plate with
optical adhesive covers (Applied Biosystems). The reac-
tions were run in a 5 μl volume in duplicate, with 2 μL of
cDNA solution, 3 μL of Oligreen stock solution (Invitro-
gen) 200× diluted in TE buffer. Fluorescence was continu-
ously read at 80°C for 1 min, a condition which ensures
exclusive cDNA measurement [43]. Measurements linear-
ity was assessed by a cDNA standard curve. After back-
ground substraction, fluorescence values were normalized
throughout all samples to be treated in the same way as
PCR-based NF values.
Data analysis
Statistical analysis
Statistical calculations were run with Microsoft Excel and
XLSTAT 2006 add-on (Addinsoft).
Confidence interval calculation
For each reference gene, groups are tested two-by-two for
their equivalences. For two groups (Ti;Tj) with the same
number of elements (N), with means ( ) and stand-
ard deviations (Si;Sj); the confidence interval is calculated
on a Microsoft Excel spreadsheet using the formula:
t 2N-2;1-α:1-α quantile of the two-tails Student t-distribu-
tion with 2N-2 degrees of freedom.
List of abbreviations
NF, Normalizing Factor; Ct, Cycle Treshold; PCR,
Polymerase Chain Reaction; qPCR, quantitative PCR;
sqPCR, semi-quantitative PCR; RT, Reverse Transcription;
GAPDH, glyceraldehyde-3P-dehydrogenase; CCI, Con-
trolled Cortical Injury; CHI, Closed Head Injury; FPI,
Fluid Percussion Injury.
Authors' contributions
HR performed all the in vitro experimental procedures
and the data analysis, and was primary author of the man-
uscript. VE and DS supervised the study design and con-
tributed to writing the manuscript. MP and C M-L
provided the experimental model of traumatic brain
injury. NC performed the experimental trauma.
L t,s =
− efft
Ct s t (,)
ˆ ; ˆ XX ij
IX X t
Si Sj
N
XXt
Si Sj
N
ij i j N i j N =− −
+
−+
+ ⎡
⎣
⎢
−− −− ˆˆ ; ˆˆ
;; 22 1 22 1
22 22
aa ⎢ ⎢
⎢
⎤
⎦
⎥
⎥
⎥
Correlation between Oligreen measurements and other reference genes Figure 6
Correlation between Oligreen measurements and other reference genes. Each point corresponds to one sample, as 
the mean of normalized measured levels for all tested reference genes in function of the normalized measured levels of Oli-
green. A 95% confidence ellipse is drawn.
 
Symbol Forward  primer  Backward  primer  From  Genbank 
accession 
β-actin  AGGTGACAGCATTGCTTCG GCTGCCTCAACACCTCAA  C  [49]  NM_007393
18s rRNA  TTGACGGAAGGGCACCACCAG GCACCACCACCCACGGAATCG [50]  V00851  
S100 β GAGCTCTCTCACTTCCTG TCACTTTGTCCACCACTTCCTG  [51] NM_009115
β-microtubulin ATTCACCCCCACTGAGACTG TGCTATTTCTTTCTGCGTGC  [52] NM_009735
GAPDH  AAGATGGTGATGGGCTTCCCG TGGCAAAGTGGAGATTGTTGCC [53]  NM_001001303BMC Molecular Biology 2008, 9:62 http://www.biomedcentral.com/1471-2199/9/62
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